Ethical issues in perinatal genetics

Seminars in Fetal and Neonatal Medicine

Volumn 16, Issue 2, 2011, Pages 70-73

  Chervenak, Frank A ^a   McCullough, Laurence B ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Beneficence; Ethics; Fetus as a patient; Perinatal genetics; Respect for autonomy; Risk assessment

Indexed keywords

ARTICLE; BENEFICENCE; FETAL WELL BEING; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC DISORDER; GENETICS; HUMAN; MEDICAL ETHICS; MEDICAL SPECIALIST; OBSTETRIC CARE; PATIENT AUTONOMY; PERINATAL GENETIC; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

ABORTION, INDUCED; FEMALE; FETUS; GENETIC DISEASES, INBORN; GENETIC TESTING; HUMANS; PATIENT RIGHTS; PERSONAL AUTONOMY; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 79951950472     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2010.10.004     Document Type: Article

References (20)

1. Beauchamp T.L., Childress J.F. Principles of biomedical ethics 2009, Oxford University Press, New York. 6th ed.
2. McCullough L.B., Chervenak F.A. Ethics in obstetrics and gynecology 1994, Oxford University Press, New York.
3. Faden R.R., Beauchamp T.L. A history and theory of informed consent 1986, Oxford University Press, New York.
4. Hack M., Fanaroff A.A. Outcomes of extremely-low-birth-weight infants between 1982 and 1988. N Engl J Med 1989, 321:1642.
5. Chervenak F.A., McCullough L.B. The limits of viability. J Perinat Med 1997, 25:418.
6. Chervenak F.A., McCullough L.B., Levene M.I. An ethically justified, clinically comprehensive approach to peri-viability: gynaecological, obstetric, perinatal, and neonatal dimensions. J Obstet Gynaecol 2007, 27:3-7.
7. Brody H. Transparency: informed consent in primary care. Hastings Cent Rep 1989, 19:5-9.
8. Wear S. Informed consent: patient autonomy and physician beneficence within health care 1998, Georgetown University Press, Washington, DC.
9. Chervenak F.A., McCullough L.B., Sharma G., Davis J., Gross S. Enhancing patient autonomy with risk assessment and invasive diagnosis: an ethical solution to a clinical challenge. Am J Obstet Gynecol 2008, 199:19.e1-19.e4.
10. American College of Obstetrics and Gynecology Committee on Practice Bulletins Screening for fetal chromosomal abnormalities. Obstet Gynecol 2007, 109:217-227.
11. Berkowitz R.L., Cuckle H.S., Wapner R., D'Alton M.E. Aneuploidy screening: what test should I use?. Obstet Gynecol 2006, 107:715-718.
12. Menutti M.T., Driscoll D.A. Screening for Down's syndrome - too many choices?. N Engl J Med 2003, 349:1471-1473.
13. Chervenak F.A., McCullough L.B. An ethically justified practical approach to offering, recommending, performing, and referring for induced abortion and feticide. Am J Obstet Gynecol 2009, 201:560.e1-560.e6.
14. Chervenak F.A., McCullough L.B., Wapner R. Three ethically justified indications for selective termination in multifetal pregnancy: a practical and comprehensive management strategy. J Assist Reprod Genet 1995, 12:531.
15. Chervenak F.A., Farley M.A., Walters L., et al. When is termination of pregnancy during the third trimester morally justifiable?. N Engl J Med 1984, 310:501.
16. Chervenak F.A., McCullough L.B., Campbell S. Is third trimester abortion justified?. Br J Obstet Gynaecol 1995, 102:434.
17. Chervenak F.A., McCullough L.B., Campbell S. Third trimester abortion: is compassion enough?. Br J Obstet Gynaecol 1999, 106:293.
18. Sen A. Inequality reexamined 1992, Harvard University Press, Cambridge, MA.
19. Chervenak F.A., McCullough L.B. Nonaggressive obstetric management: an option for some fetal anomalies during the third trimester. JAMA 1989, 261:3439.
20. Chervenak F.A., McCullough L.B. Ethical dimensions of non-aggressive fetal management. Semin Fetal Neonatal Med 2008, 13:216-219.